Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,420Revenue (TTM) $M513Net Margin (%)11.4Altman Z-Score4.3
Enterprise Value $M1,398EPS (TTM) $1.2Operating Margin %17.1Piotroski F-Score4
P/E(ttm)29.4Beneish M-Score-1.8Pre-tax Margin (%)15.9Higher ROA y-yN
Price/Book2.310-y EBITDA Growth Rate %8.0Quick Ratio6.2Cash flow > EarningsN
Price/Sales3.25-y EBITDA Growth Rate %28.1Current Ratio7.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-40.9ROA % (ttm)5.9Higher Current Ratio y-yY
Dividend Yield %--PEG1.2ROE % (ttm)9.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M41.0ROIC % (ttm)9.9Gross Margin Increase y-yN

Gurus Latest Trades with EBS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

EBS is held by these investors:



EBS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Havey AdamEVP, Biodefense Divison 2017-04-03Sell11,419$28.6221.07view
Hauer Jerome MDirector 2017-03-08Sell2,576$31.2710.81view
Bailey SueDirector 2017-01-17Sell19,424$29.7816.35view
Havey AdamEVP, Biodefense Divison 2017-01-17Sell8,438$29.7516.47view
Abdun-Nabi DanielPresident and CEO 2017-01-10Sell28,240$31.2810.77view
Richard RonaldDirector 2016-12-13Sell5,900$34.091.64view
JOULWAN GEORGE ADirector 2016-06-06Sell4,700$44.12-21.46view
Abdun-Nabi DanielPresident & CEO 2016-06-01Sell8,699$43.74-20.78view
El-Hibri FuadChairman, 10% Owner 2016-05-27Sell9,835$43.5-20.34view
El-Hibri FuadChairman, 10% Owner 2016-05-26Sell39,759$43.13-19.66view

Press Releases about EBS :

Quarterly/Annual Reports about EBS:

News about EBS:

Articles On GuruFocus.com
Biotech Has a Promising Future May 31 2017 
Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday May 25, 2017 at 9:00 AM EDT; W May 11 2017 
Emergent BioSolutions Unveils Its Expanded Center for Innovation in Advanced Development and Manufac May 10 2017 
Emergent BioSolutions to Unveil its Expanded Center for Innovation in Advanced Development and Manuf May 09 2017 
Emergent BioSolutions to Release First Quarter 2017 Financial Results and Conduct a Conference Call Apr 20 2017 
Emergent BioSolutions Signs $53 Million Modification to BARDA Contract for the Manufacture of Botuli Mar 31 2017 
Emergent BioSolutions Awarded $100 Million BARDA Contract for BioThrax Deliveries to the Strategic N Mar 17 2017 
Emergent BioSolutions Receives BARDA Task Order Valued at Up to $30.5 Million to Develop Viral Hemor Feb 13 2017 
Emergent BioSolutions to Release Fourth Quarter and Full Year 2016 Financial Results and Conduct a C Feb 09 2017 
Emergent BioSolutions Initiates NIAID-Funded Phase 1b Clinical Study to Evaluate Broad-Spectrum Anti Feb 01 2017 

More From Other Websites
Why Is Emergent Biosolutions (EBS) Up 3.9% Since the Last Earnings Report? Jun 09 2017
ETFs with exposure to Emergent BioSolutions, Inc. : June 6, 2017 Jun 06 2017
Emergent BioSolutions, Inc. breached its 50 day moving average in a Bullish Manner : EBS-US : May... May 24 2017
ETFs with exposure to Emergent BioSolutions, Inc. : May 22, 2017 May 22 2017
Emergent BioSolutions, Inc. :EBS-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017 May 19 2017
Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday May 25, 2017 at 9:00 AM EDT;... May 11 2017
Emergent BioSolutions Unveils Its Expanded Center for Innovation in Advanced Development and... May 10 2017
Edited Transcript of EBS earnings conference call or presentation 4-May-17 9:00pm GMT May 09 2017
Emergent BioSolutions to Unveil its Expanded Center for Innovation in Advanced Development and... May 09 2017
Emergent Biosolutions Inc. Moves Things Around, Still Sees Growth May 08 2017
Emergent BioSolutions, Inc. breached its 50 day moving average in a Bearish Manner : EBS-US : May 8,... May 08 2017
Emergent Biosolutions beats 1Q profit forecasts May 04 2017
Emergent BioSolutions Reports First Quarter 2017 Financial Results; Reaffirms 2017 Guidance May 04 2017
Emergent BioSolutions, Inc. – Value Analysis (NYSE:EBS) : April 27, 2017 Apr 27 2017
Emergent BioSolutions, Inc. breached its 50 day moving average in a Bullish Manner : EBS-US : April... Apr 26 2017
Emergent BioSolutions to Release First Quarter 2017 Financial Results and Conduct a Conference Call... Apr 20 2017
Emergent BioSolutions Signs $53 Million Modification to BARDA Contract for the Manufacture of... Mar 31 2017
Emergent BioSolutions, Inc. breached its 50 day moving average in a Bearish Manner : EBS-US : March... Mar 20 2017
Emergent BioSolutions gets $100 million anthrax contract from feds Mar 20 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}